Tauriga Sciences, Inc.
TAUG · OTC
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,373 | $11,448 | $16,818 | $22,073 |
| - Cash | $7 | $29 | $67 | $50 |
| + Debt | $1,513 | $1,441 | $1,066 | $569 |
| Enterprise Value | $10,880 | $12,861 | $17,816 | $22,592 |
| Revenue | $103 | $107 | $33 | $70 |
| % Growth | -4.4% | 221.7% | -52.5% | – |
| Gross Profit | $56 | $48 | $18 | $41 |
| % Margin | 54.7% | 44.8% | 54.4% | 58.4% |
| EBITDA | -$1,474 | -$1,316 | -$395 | -$1,820 |
| % Margin | -1,436.7% | -1,225.9% | -1,184.7% | -2,592% |
| Net Income | -$1,542 | -$1,736 | -$832 | -$2,012 |
| % Margin | -1,503.5% | -1,617.5% | -2,494.6% | -2,865.8% |
| EPS Diluted | -0.005 | -0.008 | -0.003 | -0.011 |
| % Growth | 28.9% | -153.3% | 73.7% | – |
| Operating Cash Flow | -$262 | -$422 | -$759 | -$1,229 |
| Capital Expenditures | $0 | $0 | -$2 | -$12 |
| Free Cash Flow | -$262 | -$422 | -$761 | -$1,241 |